Biomineralization, strength and cytocompatibility improvement of bredigite scaffolds through doping/coating
Source abstract
Abstract
Abstract Coprecipitation-derived, sacrificial polymeric (urethane) foam-fabricated bredigite (Ca7MgSi4O16) scaffolds were processed by individual and combined treatments of fluoride doping and poly (lactic-co-glycolic acid) (PLGA) coating and then studied in terms of structure, mechanical strength, bioactivity and cell biocompatibility in vitro. According to scanning electron microscopy and Archimedes porosimetry, the geometrical characteristics of pores for all the scaffolds are in the appropriate range for hard tissue regeneration applications. The apatite-formation ability of the samples immersed in a simulated body fluid is improved by doping for both the bare and coated conditions, based on microscopic and energy-dispersive X-ray spectroscopic analyses. Both the treatments advantageously buffer physiological pH changes imposed due to the fast bioresorption of the ceramic. Also, the biodegradable PLGA coating typically enhances the compressive strength of the scaffolds, which is critical for bone tissue engineering. In accordance with the MTT assay on osteoblast-like cells (MG-63) cultures, both the processes individually enhance the cell viability, while the highest improvement is obtained for the combined application of them. It is finally concluded that fluoride doping and PLGA coating are impressive approaches to improve the bioperformance of bredigite-based scaffolds.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Dental materials and restorations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. Porous diopside (CaMgSi2O6) scaffold: a promising bioactive material for bone tissue engineering10.1016/j.actbio.2009.12.022 ↗
2. Fabrication and characterization of nanostructure diopside scaffolds using the space holder method: effect of different space holders and compaction pressures10.1016/j.matdes.2015.11.078 ↗
3. Preparation of nanostructure bioactive diopside scaffolds for bone tissue engineering by two near net shape manufacturing techniques10.1016/j.matlet.2015.12.161 ↗
4. Analysis of 3D printed diopside scaffolds properties for tissue engineering
5. Strontium doping into diopside tissue engineering scaffolds10.1016/j.ceramint.2019.02.067 ↗
6. Co-incorporation of strontium and fluorine into diopside scaffolds: bioactivity, biodegradation and cytocompatibility evaluations10.1016/j.msec.2019.109752 ↗
7. Porous akermanite scaffolds for bone tissue engineering: preparation, characterization, and in vitro studies10.1002/jbm.b.30456 ↗
8. On the synthesis of nanostructured akermanite scaffolds via space holder method: the effect of the spacer size on the porosity and mechanical properties10.1016/j.jmbbm.2017.01.002 ↗
9. Microstructure, mechanical properties and in vitro bioactivity of akermanite scaffolds fabricated by laser sintering
10. Three-dimensional printing akermanite porous scaffolds for load-bearing bone defect repair: an investigation of osteogenic capability and mechanical evolution10.1177/0885328216664839 ↗
11. Hierarchically porous 3D-printed akermanite scaffolds from silicones and engineered fillers10.1016/j.jeurceramsoc.2019.06.021 ↗
12. Effect of adding nano‐titanium dioxide on the microstructure, mechanical properties and in vitro bioactivity of a freeze cast merwinite scaffold10.1002/btpr.2042 ↗
13. Effect of sintering temperature and cooling rate on the morphology, mechanical behavior and apatite-forming ability of a novel nanostructured magnesium calcium silicate scaffold prepared by a freeze casting method10.1007/s10853-013-7813-8 ↗
14. A new multifunctional monticellite-ciprofloxacin scaffold: preparation, bioactivity, biocompatibility, and antibacterial properties10.1016/j.matchemphys.2018.09.054 ↗
15. A novel bioactive porous bredigite (Ca 7 MgSi 4 O 16) scaffold with biomimetic apatite layer for bone tissue engineering10.1007/s10856-006-0083-0 ↗
16. Fabrication of bioactive porous bredigite (Ca7MgSi4O16) scaffold via space holder method10.3139/146.111597 ↗
17. Mechanical strength and biocompatibility of bredigite (Ca7MgSi4O16) tissue-engineering scaffolds modified by aliphatic polyester coatings10.1016/j.ceramint.2020.03.206 ↗
18. Degradation, bioactivity, and cytocompatibility of diopside, akermanite, and bredigite ceramics10.1002/jbm.b.30779 ↗
19. Preparation and characteristics of a calcium magnesium silicate (bredigite) bioactive ceramic10.1016/j.biomaterials.2004.09.019 ↗
20. Carbonate and fluoride incorporation in synthetic apatites: comparative effect on physico-chemical properties and in vitro bioactivity in fetal bovine serum10.1016/j.msec.2009.12.011 ↗
21. The interaction of plasma proteins with nano-size fluoride-substituted apatite powders10.1016/j.ceramint.2013.01.033 ↗
22. Fluoride-containing bioactive glasses: effect of glass design and structure on degradation, pH and apatite formation in simulated body fluid10.1016/j.actbio.2010.01.043 ↗
23. Influence of fluoride for enhancing bioactivity onto phosphate based glasses10.1016/j.jnoncrysol.2018.04.046 ↗
24. Apatite formation of bioactive glasses is enhanced by low additions of fluoride but delayed in the presence of serum proteins10.1016/j.matlet.2015.04.013 ↗
25. Structure and biomineralization of calcium silicate glasses containing fluoride ions10.2109/jcersj.111.762 ↗
26. Fluoride‐containing nanoporous calcium‐silicate MTA cements for endodontics and oral surgery: early fluorapatite formation in a phosphate‐containing solution10.1111/j.1365-2591.2011.01907.x ↗
27. Effect of the fluoride content on the bioactivity of calcium silicate-based endodontic cements10.1016/j.ceramint.2013.08.064 ↗
28. Fluoride doping into SiO2-MgO-CaO bioactive glass nanoparticles: bioactivity, biodegradation and biocompatibility assessments10.1016/j.ceramint.2018.06.222 ↗
29. Enhanced sinterability and in vitro bioactivity of diopside through fluoride doping10.1016/j.ceramint.2016.12.144 ↗
30. Structure, biomineralization and biodegradation of Ca-Mg oxyfluorosilicates synthesized by inorganic salt coprecipitation10.1016/j.ceramint.2017.05.059 ↗
31. Development of PLGA-coated β-TCP scaffolds containing VEGF for bone tissue engineering10.1016/j.msec.2016.07.011 ↗
32. Enhanced mechanical performance and biological evaluation of a PLGA coated β-TCP composite scaffold for load-bearing applications10.1016/j.eurpolymj.2011.05.004 ↗
33. Mechanical and biological properties of hydroxyapatite/tricalcium phosphate scaffolds coated with poly (lactic-co-glycolic acid)10.1016/j.actbio.2007.10.006 ↗
34. Porous calcium phosphate ceramics modified with PLGA–bioactive glass10.1016/j.msec.2006.05.008 ↗
35. Novel porous hydroxyapatite prepared by combining H2O2 foaming with PU sponge and modified with PLGA and bioactive glass10.1177/0885328206063905 ↗
36. The influences of poly (lactic-co-glycolic acid)(PLGA) coating on the biodegradability, bioactivity, and biocompatibility of calcium silicate bioceramics10.1007/s10853-011-5416-9 ↗
37. The effect of poly (lactic-co-glycolic acid)(PLGA) coating on the mechanical, biodegradable, bioactive properties and drug release of porous calcium silicate scaffolds
38. Bone morphogenic protein expression and bone formation are induced by bioactive glass S53P4 scaffolds in vivo10.1002/jbm.b.34181 ↗
39. T.M. O'Shea, X. Miao, Preparation and Characterisation of Plga-Coated Porous Bioactive Glass-Ceramic Scaffolds for Subchondral Bone Tissue Engineering, Ceramic Materials and Components for Energy and Environmental Applications, John Wiley & Sons Inc2010, pp. 517-523.10.1002/9780470640845.ch73 ↗
40. Inorganic-salt coprecipitation synthesis, fluoride-doping, bioactivity and physiological pH buffering evaluations of bredigite10.1016/j.ceramint.2020.02.107 ↗
41. Structure of fluoride-containing bioactive glasses10.1039/b900956f ↗
42. Influence of fluorine content in apatite–mullite glass‐ceramics10.1111/j.1151-2916.2000.tb01640.x ↗
43. Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size10.1089/ten.teb.2012.0437 ↗
44. Biomaterials & scaffolds for tissue engineering10.1016/S1369-7021(11)70058-X ↗
45. Bioactive materials: in vitro investigation of different mechanisms of hydroxyapatite precipitation10.1016/j.actbio.2019.11.024 ↗
46. Synthesis and characterization of novel mesoporous strontium-modified bioactive glass nanospheres for bone tissue engineering applications10.1016/j.micromeso.2019.109889 ↗
47. The apatite formation ability of CaF2 doping tricalcium silicates in simulated body fluid10.1088/1748-6041/4/4/045005 ↗
48. Effect of acidic degradation products of poly (lactic‐co‐glycolic) acid on the apatite‐forming ability of poly (lactic‐co‐glycolic) acid‐siloxane nanohybrid material10.1002/jbm.a.31405 ↗
49. Effects of poly (lactic‐co‐glycolic acid)(PLGA) degradability on the apatite‐forming capacity of electrospun PLGA/SiO2–CaO nonwoven composite fabrics10.1002/jbm.b.31578 ↗
50. CaSiO3 microstructure modulating the in vitro and in vivo bioactivity of poly (lactide‐co‐glycolide) microspheres10.1002/jbm.a.33092 ↗
51. Bone compressive strength: the influence of density and strain rate10.1126/science.996549 ↗
52. Mechanical properties of trabecular bone in the human mandible: implications for dental implant treatment planning and surgical placement10.1016/S0278-2391(99)90437-8 ↗
53. Biomechanics and mechanobiology of trabecular bone: a review
54. Calcium and cell death mechanisms: a perspective from the cell death community10.1016/j.ceca.2011.03.003 ↗
55. Cultivation of mammalian cells as aggregates in bioreactors: effect of calcium concentration of spatial distribution of viability10.1002/bit.260410203 ↗
56. Effects of sodium fluoride treatment in vitro on cell proliferation, BMP-2 and BMP-3 expression in human osteosarcoma MG-63 cells10.1007/s12011-014-0148-8 ↗